Sentences with phrase «by cancer compared»

Almost one in three deaths (32 %) in men were caused by cancer compared with 29 % for cardiovascular disease.

Not exact matches

Comparing the teaching of one of the best scrutinized and accepted (and best supported by evidence) scientific theories to selling a product known to cause cancer is actually quite funny.
In addition, an analysis of the corrected rates over the decade revealed that white women's rates of death from cervical cancer decreased by 0.8 percent per year, compared with an annual decrease of 3.6 percent in black women.
In women, death rates from breast and colorectal cancer will fall by 8 % and 7 % respectively, but lung and pancreatic cancer rates will rise by 5 % and 4 %; in 2016 the death rates from lung cancer in Europe will be 14.4 per 100,000 women (compared to 13.51 in 2011) and 5.6 per 100,000 for pancreatic cancer (compared to 5.39 in 2011).
By comparing with other already known factors, HAND2 methylation is by far the most common molecular alteration in endometrial canceBy comparing with other already known factors, HAND2 methylation is by far the most common molecular alteration in endometrial canceby far the most common molecular alteration in endometrial cancer.
So says a five - year retrospective study led by Malcolm Dunlop of the University of Edinburgh, UK, that compared the aspirin habits of 2800 people with cancer and 3000 without.
Two studies published by JAMA compare certain outcomes of robotic - assisted vs laparoscopic surgery for kidney removal or rectal cancer.
A fundamental error, according to several epidemiologists, is that Tsuda compared the results of the Fukushima survey, which used advanced ultrasound devices that detect otherwise unnoticeable growths, with the roughly three cases of thyroid cancer per million found by traditional clinical examinations of patients who have lumps or symptoms.
In testing on two mouse cell lines, the drug combination reduced the viability of cancer cells by about 50 percent when compared with everolimus alone, according to the findings.
These carriers were found to have only a 56 % chance of developing breast cancer by age 70, compared with a figure of 87 % in previous studies.
Analysis of the data indicated that compared to no screening, flexible sigmoidoscopy screening reduced colorectal cancer incidence by 20 percent (absolute difference, 28.4 cases / 100, 000 person years) and colorectal cancer mortality by 27 percent (absolute difference, 11.7 deaths / 100, 000 person years).
Albiges's team followed up on Furberg and Hakimi's work by comparing survival rates of normal weight and obese individuals with kidney cancer that had metastasized.
By comparing women in the lowest - BMI category with those in successively higher ones, they found a steadily decreasing risk of the cancer.
Researchers from BUSM and the University of Cyprus compared the markers on the surface of the cancer cells to gene expression profile of breast tumors deposited by researchers in international public databases and found that a molecule named IL13RA2 (IL13R alpha2) was abundant in metastatic or late - stage BLBC.
In tumors formed by human breast cancer cells, DNA damage (brown staining) is increased by simultaneous Olaparib treatment and PGAM1 suppression (right) when compared to either Olaparib treatment (left) or PGAM1 suppression (center) alone.
In a randomized, phase 2 multi-center clinical study, led by Manisha Shah, MD of The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), investigators tested the effectiveness of the targeted therapy drug, dabrafenib (pronounced «da bRAF e nib» and marketed as Tafinlar), given alone compared with the same drug given in combination with trametinib (pronounced «tra ME ti nib,» marketed at MeKinist) to treat a subset of advanced papillary thyroid cancer patients with B - raf mutaCancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), investigators tested the effectiveness of the targeted therapy drug, dabrafenib (pronounced «da bRAF e nib» and marketed as Tafinlar), given alone compared with the same drug given in combination with trametinib (pronounced «tra ME ti nib,» marketed at MeKinist) to treat a subset of advanced papillary thyroid cancer patients with B - raf mutaCancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), investigators tested the effectiveness of the targeted therapy drug, dabrafenib (pronounced «da bRAF e nib» and marketed as Tafinlar), given alone compared with the same drug given in combination with trametinib (pronounced «tra ME ti nib,» marketed at MeKinist) to treat a subset of advanced papillary thyroid cancer patients with B - raf mutacancer patients with B - raf mutations.
Among healthy postmenopausal women, supplementation with vitamin D3 and calcium compared with placebo did not result in a significantly lower risk of cancer after four years, according to a study published by JAMA.
By comparing normal cells to cancer cells, scientists can then identify the changes that lead to disease.
The enrichment factor described how frequently cancer associated genes were identified compared to the frequency of identification that one could expect by pure chance.
The period of time before ovarian cancer recurred (called progression - free survival) improved by nearly 3.5 months with the additional drug (13.8 months compared with 10.4 months for the woman on chemotherapy alone).
The team was led by Dr Stephen Royle reader and senior Cancer Research UK fellow at Warwick Medical School said: «We've compared our method to «hot - wiring» a car.
They estimate that this screening strategy would reduce lung cancer mortality by 9.05 % compared to no screening, with an incremental cost - effectiveness ratio of $ 41,136 Canadian dollars per life - year gained.
They tested DBT and DM according to four outcomes — true positive (TP), true negative (TN), false positive (FP), and false negative (FN) rates — by comparing the Breast Imaging Reporting and Data System (BI-RADS) score (assigned at screening with data about subsequent cancer diagnosis).
«The genome of these cancer cells is less abnormal as compared to cancers caused by tobacco and alcohol, where there are even more mutations present,» he says.
The researchers were able to replicate this finding by comparing the healthy thyroid tissues in GTEx to 500 samples taken from thyroid tumors, compiled by The Cancer Genome Atlas, and giving support to the extensive impact of FOXE1 on cellular state.
A new study by UCLA scientists has found that women diagnosed with breast cancer and treated with a one - week regimen of partial breast radiation after the surgical removal of the tumor, or lumpectomy, saw no increase in cancer recurrence or difference in cosmetic outcomes compared to women who received radiation of the entire breast for a period of up to six weeks after surgery.
Most excitingly, by comparing between individual cells, the team expect to reveal differences which could play key roles in both the early stages of life and the first stages of diseases such as cancer.
However, CVD is the top killer of women in Europe, resulting in 51 % of deaths compared to 3 % caused by breast cancer
When comparing the cancer risk of EPIC participants with extremely high or extremely low immunoCRIT, the researchers found that if the value is strongly increased, the lung cancer risk rises by 100 percent, and the risk of colon cancer by approximately 60 percent.
The researchers, funded by the Medical Research Council (MRC), the Wellcome Trust and Cancer Research UK, compared the effects of two cancer - causing chemicals in normal mice and mice with the barrier defect (the knock - out Cancer Research UK, compared the effects of two cancer - causing chemicals in normal mice and mice with the barrier defect (the knock - out cancer - causing chemicals in normal mice and mice with the barrier defect (the knock - out mice).
An additional set of 18 prostate cancer tissue samples was analyzed by qPCR and five lncRNAs were found to be significantly higher in prostate tumor tissues compared with matched normal tissues.
Women whose mothers had elevated levels of DDT in their blood had a nearly fourfold increase in risk of developing breast cancer by age 52, compared with controls who were matched for a variety of factors, including maternal history of breast cancer.
Women with heart failure after cancer treatment were more likely to be treated with standard medications if seen by a cardiologist compared with those who did not see a cardiologist.
«Once identified, we further tested their role as cancer drivers, for example by looking at molecules with and without mutations and comparing their structure and function,» he adds.
The data for the current analysis compared the effect of selenium and vitamin E, taken either alone or combined, on prostate cancer risk among 1,739 men who were diagnosed with prostate cancer and, for comparison purposes, a random sample of 3,117 men without prostate cancer who were matched to the cases by race and age.
Mortality in prostate cancer is lower in areas with frequent use of PSA testing compared with areas with little testing shows a study published online today in Journal of the National Cancer Institute by researchers from Umeå University, Sweden and Memorial Sloan Kettering Cancer Center, New York, NYcancer is lower in areas with frequent use of PSA testing compared with areas with little testing shows a study published online today in Journal of the National Cancer Institute by researchers from Umeå University, Sweden and Memorial Sloan Kettering Cancer Center, New York, NYCancer Institute by researchers from Umeå University, Sweden and Memorial Sloan Kettering Cancer Center, New York, NYCancer Center, New York, NY, USA.
Given the widespread use of the HeLa cell line, Lars Steinmetz and his colleagues at EMBL decided that conducting an extensive analysis of its genome could illustrate the changes caused by cancer — and also help researchers compare versions of the cell line that have evolved over decades of growth in labs around the world.
A team led by James Farrell of the University of California, Los Angeles, compared the bacteria in the mouths of 10 healthy people with those in 10 people with pancreatic cancer.
They started by comparing cancer stem cells to noncancerous neural stem cells.
When they compared the timing and provision of hospice care between patients treated by the VA and those who received care paid for by Medicare, they discovered differences that could not be explained by cancer types.
The men receiving docetaxel had an average of 32.7 months before the cancer progressed by worsening scan results or symptoms, compared to 19.8 months for hormone therapy alone.
The international team of researchers modeled the lifetime risk of women developing radiation - induced breast cancer from digital screening mammography and dying from the disease compared to the number of breast cancer deaths prevented by early detection.
Head and neck cancers survival in England is generally higher for people diagnosed aged 15 - 49 compared with other age groups, though the association with age varies by subtype.
The team compared «age and gender - specific incidence rates of 19,858 male and 14,222 females diagnosed with brain cancer between 1982 and 2012, and mobile phone usage data from 1987 to 2012,» writes lead researcher Simon Chapman in the study, published by
By comparing different generations at similar ages, it found that people born around 1990 have double the risk of colon cancer and quadruple the risk of rectal cancer of people born around 1950.
Patients with metastatic castration - resistant prostate cancer (CRPC) had higher prostate - specific antigen (PSA) response when treated with enzalutamide compared with abiraterone / prednisone, but had no difference in time to progression or time to PSA progression, according to the results of a study (abstract 5002) presented by Kim N. Chi, MD, of the British Columbia Cancer Agency in Vancouver, at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 2 &mdacancer (CRPC) had higher prostate - specific antigen (PSA) response when treated with enzalutamide compared with abiraterone / prednisone, but had no difference in time to progression or time to PSA progression, according to the results of a study (abstract 5002) presented by Kim N. Chi, MD, of the British Columbia Cancer Agency in Vancouver, at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 2 &mdaCancer Agency in Vancouver, at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 2 — 6.
The addition of metronomic chemotherapy to dual HER2 blockade increased progression - free survival (PFS) by 7 months compared with HER2 blockade alone in older and frail patients with HER2 - positive metastatic breast cancer, according to a new study.
Led by St. Jude and the German Cancer Research Center, an international research team used molecular techniques to compare hundreds of tumors classified as CNS - PNET to other known brain tumors.
A new technique of robotic partial nephrectomy has the potential for better preservation of kidney function and better cancer control during partial nephrectomy by allowing surgeons more time to perform the procedure compared with traditional open surgery, according to the results of a recently published case series.
When tested on 335 high - risk lesions, the model correctly diagnosed 97 percent of the breast cancers as malignant and reduced the number of benign surgeries by more than 30 percent compared to existing approaches.
a b c d e f g h i j k l m n o p q r s t u v w x y z